Description

Ramiven 200 mg (Abemaciclib)

Ramiven 200 mg contains Abemaciclib 200 mg, a prescription medicine belonging to the class of CDK4/6 inhibitors. It is used primarily in the treatment of certain types of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer.

Abemaciclib works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), proteins that help regulate cell division. Blocking these proteins can slow or stop the growth and multiplication of certain cancer cells.

Product Information

Product Name	Ramiven 200 mg
Generic Name	Abemaciclib
Strength	200 mg
Drug Class	CDK4/6 Inhibitor
Therapeutic Use	Breast Cancer
Dosage Form	Tablet
Route of Administration	Oral
Prescription Status	Prescription Medicine

Uses of Ramiven 200 mg

Ramiven 200 mg may be prescribed for certain patients with:

• Hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer

• HR+, HER2-negative early breast cancer at high risk of recurrence, in appropriate patients and treatment settings

• Advanced or metastatic breast cancer in combination with endocrine therapy

• Certain breast cancer treatment regimens where abemaciclib is used as monotherapy after progression on endocrine therapy

The exact indication and treatment combination depend on the patient’s cancer characteristics, previous treatment, and the prescribing oncologist’s assessment.

How Ramiven 200 mg Works

Abemaciclib selectively inhibits CDK4 and CDK6.

These enzymes are involved in the transition of cells from the G1 phase to the S phase of the cell cycle. By inhibiting CDK4/6 activity, abemaciclib can prevent certain cancer cells from progressing through the cell cycle and multiplying.

This helps slow the growth and spread of susceptible breast cancer cells.

Benefits of Ramiven 200 mg

• Helps slow the growth of certain breast cancer cells

• Targets CDK4/6 pathways involved in cancer-cell proliferation

• Used in specific HR-positive, HER2-negative breast cancer treatment regimens

• Can be combined with endocrine therapy in appropriate patients

• May be used in both certain early and advanced/metastatic breast cancer settings

Directions for Use

Take Ramiven 200 mg exactly as prescribed by your oncologist.

Abemaciclib is generally taken twice daily, approximately 12 hours apart, when prescribed in the standard dosing schedule. However, the appropriate dose may be different depending on the treatment regimen, side effects, liver function, and other medicines being used.

Swallow the tablet whole with water. Do not crush, chew, or break the tablet unless specifically instructed by your healthcare professional.

If you miss a dose or vomit after taking a dose, follow your oncologist’s instructions rather than taking an additional dose on your own.

Possible Side Effects

Common side effects of abemaciclib may include:

• Diarrhea

• Nausea

• Vomiting

• Abdominal pain

• Decreased appetite

• Fatigue

• Headache

• Hair thinning or hair loss

• Decreased blood cell counts

• Increased liver enzymes

One of the most characteristic adverse effects is diarrhea, which can sometimes be severe and may lead to dehydration.

Serious Side Effects

Abemaciclib can cause serious adverse effects, including:

• Severe diarrhea and dehydration

• Neutropenia and other blood-cell abnormalities

• Serious infections

• Liver toxicity

• Venous thromboembolism

• Interstitial lung disease/pneumonitis

Contact your healthcare team promptly if you develop severe or persistent diarrhea, fever, signs of infection, unusual bleeding, yellowing of the skin or eyes, shortness of breath, chest pain, or sudden swelling or pain in an arm or leg.

Precautions

Before starting Ramiven, inform your oncologist if you have liver or kidney problems, a history of blood clots, or other significant medical conditions.

Your healthcare team may regularly monitor:

• Complete blood counts

• Liver function

• Kidney function

• Symptoms of infection

• Signs of blood clots

• Diarrhea and dehydration

Abemaciclib can interact with several medicines, particularly medicines that affect CYP3A4. Tell your doctor and pharmacist about all prescription medicines, over-the-counter medicines, and supplements you use.

Avoid grapefruit and grapefruit juice unless your healthcare professional specifically confirms that they are appropriate during treatment.

Frequently Asked Questions

What is Ramiven 200 mg used for?

Ramiven 200 mg contains abemaciclib and is used in certain treatment regimens for HR-positive, HER2-negative breast cancer, including some early, advanced, and metastatic breast cancer settings.

What is the generic name of Ramiven 200 mg?

The active ingredient is Abemaciclib 200 mg.

What type of medicine is Abemaciclib?

Abemaciclib is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, a targeted anticancer medicine.

How does Ramiven 200 mg work?

It inhibits CDK4 and CDK6 proteins that help cancer cells progress through the cell cycle. This can slow the multiplication of susceptible cancer cells.

Is Ramiven 200 mg a chemotherapy medicine?

Abemaciclib is a targeted anticancer therapy rather than a traditional cytotoxic chemotherapy. It specifically targets CDK4/6 pathways involved in cell-cycle progression.

How often is Ramiven 200 mg taken?

When used at the standard 200 mg dose, abemaciclib is generally taken twice daily. The actual dose and schedule should always follow the oncologist’s prescription.

Does Ramiven 200 mg cause diarrhea?

Yes. Diarrhea is one of the most common side effects of abemaciclib. Contact your healthcare team if diarrhea is severe or persistent because dehydration can occur.

Can Ramiven 200 mg affect blood counts?

Yes. Abemaciclib can reduce certain blood-cell counts, including neutrophils, red blood cells, and platelets. Regular blood tests may therefore be required during treatment.

Can Ramiven 200 mg affect the liver?

Yes. Abemaciclib can increase liver enzymes and, in some cases, cause significant liver problems. Your doctor may perform regular liver-function tests.

Can Ramiven 200 mg be taken during pregnancy?

Abemaciclib may cause fetal harm. Patients who could become pregnant should discuss appropriate contraception and pregnancy precautions with their healthcare professional before and during treatment.

Is Ramiven 200 mg a prescription medicine?

Yes. Ramiven 200 mg is a prescription anticancer medicine and should be used under the supervision of an oncologist or other qualified healthcare professional.